UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.39 billion. The enterprise value is $1.50 billion.
| Market Cap | 1.39B |
| Enterprise Value | 1.50B |
Important Dates
The last earnings date was Wednesday, November 19, 2025, after market close.
| Earnings Date | Nov 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.43 million shares outstanding. The number of shares has increased by 9.37% in one year.
| Current Share Class | 54.43M |
| Shares Outstanding | 54.43M |
| Shares Change (YoY) | +9.37% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 2.50% |
| Owned by Institutions (%) | 88.65% |
| Float | 49.65M |
Valuation Ratios
The trailing PE ratio is 22.57 and the forward PE ratio is 33.63. UTI's PEG ratio is 2.24.
| PE Ratio | 22.57 |
| Forward PE | 33.63 |
| PS Ratio | 1.66 |
| Forward PS | 1.51 |
| PB Ratio | 4.23 |
| P/TBV Ratio | 4.92 |
| P/FCF Ratio | 25.08 |
| P/OCF Ratio | 14.26 |
| PEG Ratio | 2.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.86, with an EV/FCF ratio of 27.05.
| EV / Earnings | 23.76 |
| EV / Sales | 1.79 |
| EV / EBITDA | 12.86 |
| EV / EBIT | 17.93 |
| EV / FCF | 27.05 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.07 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 5.04 |
| Interest Coverage | 14.83 |
Financial Efficiency
Return on equity (ROE) is 21.42% and return on invested capital (ROIC) is 8.98%.
| Return on Equity (ROE) | 21.42% |
| Return on Assets (ROA) | 6.65% |
| Return on Invested Capital (ROIC) | 8.98% |
| Return on Capital Employed (ROCE) | 14.00% |
| Revenue Per Employee | $203,809 |
| Profits Per Employee | $15,370 |
| Employee Count | 4,100 |
| Asset Turnover | 1.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $21.26 million in taxes.
| Income Tax | 21.26M |
| Effective Tax Rate | 25.22% |
Stock Price Statistics
The stock price has increased by +2.74% in the last 52 weeks. The beta is 1.37, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | +2.74% |
| 50-Day Moving Average | 29.33 |
| 200-Day Moving Average | 29.61 |
| Relative Strength Index (RSI) | 44.49 |
| Average Volume (20 Days) | 926,869 |
Short Selling Information
The latest short interest is 2.04 million, so 3.75% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 3.75% |
| Short % of Float | 4.11% |
| Short Ratio (days to cover) | 3.46 |
Income Statement
In the last 12 months, UTI had revenue of $835.62 million and earned $63.02 million in profits. Earnings per share was $1.13.
| Revenue | 835.62M |
| Gross Profit | 471.09M |
| Operating Income | 83.51M |
| Pretax Income | 84.27M |
| Net Income | 63.02M |
| EBITDA | 116.47M |
| EBIT | 83.51M |
| Earnings Per Share (EPS) | $1.13 |
Balance Sheet
The company has $169.56 million in cash and $278.90 million in debt, giving a net cash position of -$109.34 million or -$2.01 per share.
| Cash & Cash Equivalents | 169.56M |
| Total Debt | 278.90M |
| Net Cash | -109.34M |
| Net Cash Per Share | -$2.01 |
| Equity (Book Value) | 328.11M |
| Book Value Per Share | 6.03 |
| Working Capital | 16.96M |
Cash Flow
In the last 12 months, operating cash flow was $97.33 million and capital expenditures -$41.98 million, giving a free cash flow of $55.35 million.
| Operating Cash Flow | 97.33M |
| Capital Expenditures | -41.98M |
| Free Cash Flow | 55.35M |
| FCF Per Share | $1.02 |
Margins
Gross margin is 56.38%, with operating and profit margins of 9.99% and 7.54%.
| Gross Margin | 56.38% |
| Operating Margin | 9.99% |
| Pretax Margin | 10.09% |
| Profit Margin | 7.54% |
| EBITDA Margin | 13.94% |
| EBIT Margin | 9.99% |
| FCF Margin | 6.62% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.37% |
| Shareholder Yield | -9.37% |
| Earnings Yield | 4.54% |
| FCF Yield | 3.99% |
Analyst Forecast
The average price target for UTI is $36.80, which is 44.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.80 |
| Price Target Difference | 44.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.31 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 7 |